Articles that mention Valeant Pharmaceuticals -BoardProspects

Valeant Pharmaceuticals

0 Comments Leave a Comment

1-15 of 35 1 2 3 »
1. Mentioned In 35 Articles
2. What We Can Learn From Bill Ackman's Comeback
  
  Explore gurufocus.com Jun 17 2019 BoardBlogs
  
  ...em Ackman's problems in 2016 and 2015 were well publicized. He decided to bet heavily on pharmaceutical group Valeant Pharmaceuticals, which at one point was his most significant single position. But after peaking in sum...
  Read Full Article
  
  Comment
  
  Mentions: Investors Bill Ackman Warren Buffett
3. Stoke Therapeutics Appoints Jennifer Burstein to its Board of Directors
  
  Explore businesswire.com Jun 14 2019 BoardMoves
  
  ...ore that, she worked on the finance team at Eyetech Pharmaceuticals, Inc., which is currently a subsidiary of Valeant Pharmaceuticals International, Inc. Earlier in her career, Ms. Burstein worked in the finance departme...
  Read Full Article
  
  Comment
  
  Mentions: Twitter acquisition Valeant Pharmaceuticals
4. Bill Ackman's Pershing Square is up More Than 24% So Far This Year
  
  Explore Yahoo Finance Feb 13 2019 BoardNews
  
  ...ent in 2018. Some of Pershing's challenges over the past few years included a $4 billion loss on its stake in Valeant Pharmaceuticals. Ackman's short of nutritional supplement company Herbalife proved costly not only in ...
  Read Full Article
  
  Comment
  
  Mentions: Hedge Fund Bill Ackman Starbucks
5. LifePoint Board OK with $120 Million Pay Plan Despite Shareholder Rejection
  
  Explore modernhealthcare.com Nov 3 2018 BoardNews
  
  ...irectors and executives, unless they're structured in a way that doesn't permit changes. One example was when Valeant Pharmaceuticals' CEO agreed to forgo a massive stock award after shareholders expressed opposition.“So...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Attorneys
6. Starbucks Spikes After Hedge-Fund Billionaire Bill Ackman Discloses a Stake in the Company
  
  Explore Stock Market Data Today Oct 9 2018 BoardNews
  
  ...another billionaire investor, who was bullish on the company. He also saw big losses on a position he held in Valeant Pharmaceuticals. Reuters reported in January that Ackman sought to lower his profile and turn around h...
  Read Full Article
  
  Comment
  
  Mentions: Conference Activist Investors Management
7. Nestle Puts Skin-Health Unit Up for Possible $8 Billion Sale -
  
  Explore BNN Bloomberg Sep 20 2018 BoardNews
  
  ...ut in 2014 and in the following months paid a further $1.4 billion to buy a portfolio of skin-care drugs from Valeant Pharmaceuticals. This week Nestle agreed to sell Gerber Life Insurance to Western & Southern Financial...
  Read Full Article
  
  Comment
  
  Mentions: Starbucks Sale Nestle
8. Is This the End of Activist Investing?
  
  Explore FoxBusiness.com Apr 6 2018 BoardBlogs
  
  ...lar rate this year, one source told the WSJ. Ackman has recently made a few bad bets, including Herbalife and Valeant Pharmaceuticals. But while Pershing Square is reportedly seeing investors cash out, overall shareholde...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Management Investors
9. Has Bill Ackman Lost His Touch? Pershing Investors Say Yes
  
  Explore Fool.com Apr 5 2018 BoardBlogs
  
  ...et earlier this year. Ackman has also made missteps on the bullish side of the spectrum. His calls supporting Valeant Pharmaceuticals International led to massive investments from Pershing Square in the controversial pha...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Management Investors
10. Three Activist Hedge Funds to Watch
  
  Explore Stock Market Today Jan 23 2018 BoardBlogs
  
  ... Oplink Communications, Obagi Medical Products Inc., and Solta Medical Inc. Solta and Obagi were both sold to Valeant Pharmaceuticals International Inc. for significant premiums, helping drive Voce's returns. Land & Buil...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management Hedge Fund
11. Jeffrey Ubben Joins AES Board of Directors
  
  Explore businesswire.com Jan 18 2018 BoardMoves
  
  ...of Twenty-First Century Fox Inc., and is a former Director of Gartner Group, Inc., Misys plc, Sara Lee Corp., Valeant Pharmaceuticals International and Willis Towers Watson plc, as well as other public and private compan...
  Read Full Article
  
  Comment
  
  Mentions: Management Audit Committee SEC
12. Valeant CEO Papa says Drugmaker has 'Turnaround Opportunity of a Lifetime'
  
  Explore bnn.ca Jan 10 2018 BoardNews
  
  ...d during a presentation Wednesday at the J.P. Morgan Healthcare Conference in San Francisco... (Bloomberg) -- Valeant Pharmaceuticals International Inc. became a household name with its historic rise and fall. Reviving t...
  Read Full Article
  
  Comment
  
  Mentions: Conference Bill Ackman Valeant Pharmaceuticals
13. Pershing Square, Valeant asked to appear for hearing on insider trading suit (VRX, Agn)
  
  Explore Stock Market Data Today Jan 3 2018 BoardNews
  
  ...iscuss the proposed settlement in an insider trading lawsuit. Jan 2 (Reuters) - A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a ...
  Read Full Article
  
  Comment
  
  Mentions: Management Bill Ackman lawsuit
14. Top Canadian CEOs made more than 200 times average worker — study
  
  Explore Jamaica Observer Jan 3 2018 BoardNews
  
  ... highest paid among them were raking in record-breaking earnings,” said the report's author, David Macdonald. Valeant Pharmaceuticals' CEO Joseph Papa was the best paid in 2016, making Can$83.1 million in eight months on...
  Read Full Article
  
  Comment
  
  Mentions: crisis Valeant Pharmaceuticals stock options
15. Pershing Square, Valeant Arrive at Settlement Split for Allergan Lawsuit
  
  Explore reuters.com Dec 30 2017 BoardNews
  
  ...before bidding for Allergan Plc ... (Reuters) - Activist investor William Ackman’s Pershing Square PHS.AS and Valeant Pharmaceuticals (VRX.TO) on Friday decided to pay $290 million to settle a lawsuit that accused them o...
  Read Full Article
  
  Comment
  
  Mentions: Management Bill Ackman lawsuit
16. Bill Ackman Just \Took a $200 Million Hit to His Reputation
  
  Explore Business Insider Dec 29 2017 BoardNews
  
  $Bill Ackman Just \Took a $200 Million Hit to His Reputation$
  ...ettlement has been reached in the insider trading case against Bill Ackman's hedge fund, Pershing Square, and Valeant Pharmaceuticals. "Pershing Square and Valeant have agreed to split the $290 million total settlement s...
  Read Full Article
  
  Comment
  
  Mentions: hostile takeover Bill Ackman crisis
17. 1-15 of 35 1 2 3 »